<?xml version="1.0" encoding="UTF-8"?>
<p>In January 2020, a 35-year-old male infected with COVID-19 was compassionately treated with intravenous remdesivir after developing pneumonia in the USA.
 <xref rid="cit0027" ref-type="bibr">27</xref> The patient was hospitalized for more than 12 days, ntravenous remdesivir was administrated for 7 days and the patient's condition was apparently improved on the eighth day.
 <xref rid="cit0027" ref-type="bibr">27</xref> No adverse effect associated with administration of remdesivir was reported.
</p>
